Compound ID | 1311
Omodenbamab
Synonym(s): 514G3 | 514-G3 | 514 G3
Class: Antibody
| Agent Type: | Natural product; Indirect acting; Antivirulence; Antibody; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Targets the staphylococcal protein A |
| Target Pathogen: | Adjunctive treatment of bloodstream infections caused by S. aureus |
| Institute where first reported: | XBiotch |
| Highest development stage: | Phase 1/2 (NCT02357966) |
| Development status: | Active |
| External links: | |
| Guide to Pharmacology: | omodenbamab |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.